5. Kwatanta adadin adana ganye
Babban makasudin magance kwari shine hana kwari cutar da amfanin gona. Dangane da ko kwaroron sun mutu da sauri ko a hankali, ko fiye ko žasa, lamari ne na fahimtar mutane. Adadin adana ganye shine madaidaicin alamar ƙimar samfurin.
Don kwatanta tasirin sarrafawa na rollers leaf shinkafa, adadin adana ganye na lufenuron zai iya kaiwa fiye da 90%, Emamectin Benzoate zai iya kaiwa 80.7%, indoxacarb na iya kaiwa 80%, Chlorfenapyr na iya kaiwa kusan 65%.
Yawan adana ganye: lufenuron> Emamectin Benzoate> Indoxacarb> Chlorfenapyr
6. Kwatancen tsaro
Lufenuron: Ya zuwa yanzu, babu illa masu illa. A lokaci guda, wannan wakili ba zai haifar da sake kamuwa da kwari masu tsotsa ba kuma yana da tasiri mai laushi akan manya masu amfani da kwari da gizo-gizo.
Chlorfenapyr: Mai hankali ga kayan lambu da kayan lambu na guna, yana da haɗari ga phytotoxicity lokacin amfani dashi a yanayin zafi ko a cikin manyan allurai;
Indoxacarb: Yana da aminci sosai kuma ba shi da illa. Ana iya debo kayan lambu ko 'ya'yan itatuwa a ci washegarin bayan an shafa maganin kashe kwari.
Emamectin Benzoate: Yana da aminci sosai ga duk amfanin gona a wuraren da aka karewa ko kuma sau 10 da aka ba da shawarar. Yana da maganin kashe qwari maras illa ga muhalli.
Tsaro: Emamectin Benzoate ≥ indoxacarb> lufenuron> Chlorfenapyr
7. Kwatancen farashin magani
An ƙididdige shi bisa ƙididdiga da ƙididdiga na masana'antun daban-daban a cikin 'yan shekarun nan.
Kwatanta farashin magani shine: indoxacarb> Chlorfenapyr> lufenuron> Emamectin Benzoate
Gabaɗaya ji na potions biyar a ainihin amfani:
A karo na farko da na yi amfani da lufenuron, na ji cewa tasirin ya kasance matsakaici. Bayan amfani da shi sau biyu a jere, sai na ji cewa tasirin yana da ban mamaki sosai.
A gefe guda, na ji cewa tasirin fenfonitrile yana da kyau sosai bayan amfani da farko, amma bayan amfani guda biyu a jere, sakamakon ya kasance matsakaici.
Tasirin Emamectin Benzoate da indoxacarb suna kusan tsakanin.
Game da halin da ake ciki na juriya na kwari a halin yanzu, ana ba da shawarar yin amfani da tsarin "rigakafi na farko, cikakkiyar rigakafi da sarrafawa", da kuma ɗaukar matakan (na jiki, sinadarai, nazarin halittu, da dai sauransu) a farkon abubuwan da suka faru don ingantaccen rigakafi da sarrafawa, ta haka ne. rage adadin da adadin magungunan kashe qwari a cikin lokaci na gaba da jinkirta juriya na magungunan kashe qwari. .
Lokacin amfani da magungunan kashe qwari don rigakafi da sarrafawa, ana ba da shawarar a haɗa magungunan kashe qwari da aka samu daga shuka ko na halitta irin su pyrethrins, pyrethrins, matrines, da dai sauransu, a haxa su da jujjuya su da sinadarai don cimma manufar rage juriya na miyagun ƙwayoyi; Lokacin amfani da sinadarai, ana ba da shawarar yin amfani da shirye-shiryen fili kuma a yi amfani da su a madadin don cimma sakamako mai kyau na sarrafawa.
Lokacin aikawa: Dec-18-2023